News
Now Iktos teams up with Pierre Fabre in oncology
As Servier announces its partnership with Paris, France-based Iktos, now Pierre Fabre Laboratories has revealed an integrated collaboration with Iktos
News
Parabilis scores $305m in bumper biofinancing week
Money has flooded into biotechs this week, with Parabilis raising $305m and five other start-ups closing nine-figure private rounds.
News
Report says MSD is in talks to buy Revolution Meds
MSD is rumoured to be in talks to buy Revolution Medicines and its KRAS inhibitor pipeline in a deal that could be worth up to $32 billion.
News
Hengrui gets first OK for a PD-L1/TGF-beta drug for cancer
Hengrui has achieved a milestone in oncology as retlirafusp alfa is approved in China, its first world market, for gastric cancer.
News
Amgen inks $840m takeover of UK's Dark Blue Therapeutics
Amgen has added a new acute myeloid leukaemia drug with the takeover of Dark Blue Therapeutics and its first-in-class MLLT 1/3 degrader.
News
Views & Analysis
Deep Dive
Editor's Picks
Editor's Picks
